Viral Clearance Market Analysis | 2023-2028

Market Insights

The Viral Clearance Market was estimated at US$ 566.94 million in 2022 and is expected to grow at an impressive CAGR of 21.6% during 2023-2028 to reach US$ 1837.43 million by 2028.

Wish to get a free sample? Register Here

What is Viral Clearance?

Viral clearance is a meticulous process aimed at eliminating viral contamination from pharmaceutical and biotechnological products. Employing techniques such as chromatography and specialized membrane applications, this critical step ensures that drugs from various sources are free from any viral impurities. The two primary methods involved in viral clearance are viral removal and viral inactivation.

This safeguarding process is crucial in industries like biotechnology and pharmaceuticals, where maintaining the purity and safety of products is paramount. Academic research institutes and contract research organizations also rely on viral clearance to meet stringent standards, emphasizing its essential role in upholding the integrity of drugs and biotechnological advancements.

Market Dynamics

The key factors driving the growth of the viral clearance market are as follows-

• Rising Prevalence of Viral Infections: The market is experiencing substantial growth due to an increase in viral infections, prompting a heightened demand for effective viral clearance measures.

• Demand Surge in Biopharmaceutical Products: Growing demand for biopharmaceutical products, coupled with stringent safety regulations, is a significant driver for market expansion.

• Shift Towards Advanced Technologies: Notable adoption of advanced viral clearance technologies, including filtration, chromatography, and viral inactivation methods, is observed. These technologies enhance the removal and inactivation of viruses during the manufacturing of biopharmaceutical products.

• Response to Novel Virus Emergence: The emergence of new viruses has necessitated robust viral clearance methods, contributing to the increased demand for advanced technologies.

• Research and Development Investments: Significant investments in research and development within the life sciences sector, facilitated by collaborations between pharmaceutical companies and research organizations, are driving market growth.

• Industry Growth and Drug Launches: The expansion of the pharmaceutical and biotechnology industries, coupled with a surge in drug launches, has created a heightened demand for viral clearance technologies.

• Advances in Nanofiltration Technology: Market growth is further boosted by advances in nanofiltration technology, providing efficient capabilities for viral removal in the manufacturing process.

• Addressing the Burden of Chronic Diseases: The escalating burden of chronic diseases, often requiring the use of biopharmaceutical products, intensifies the need for robust viral clearance methods.

In conclusion, the viral clearance market is witnessing significant growth driven by a confluence of factors, including technological advancements, industry expansion, and the imperative to address emerging viral threats and chronic diseases.

Segments Analysis

By End-User Type

The viral clearance market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and others. The contract research organizations segment is expected to portray the highest growth during the forecast period. The ability of contract research organizations to invest extensively in drug discovery infrastructure and increased outsourcing of drug discovery services to CROs by institutions, such as start-ups, academic institutes, pharmaceutical companies, and small biotechnology companies are the major factors behind their extraordinary growth in the global viral clearance market.

By Method Type

The market is segmented as viral removal and viral inactivation. The viral removal segment is expected to lead the market during the forecast period owing to growth in R&D activities by biopharmaceutical companies; high accuracy, speed, and flexibility provided by the method in life sciences research, and increasing acceptance of the method in the industry.

Regional Analysis

In terms of regions, North America dominated the viral clearance market and is expected to witness substantial growth during the forecast period. The presence of national institutes supporting life science and biotechnology research, significant growth in the pharmaceutical industry, and continuous increase in drug approvals are the major factors driving the viral clearance market in the region.

Asia-Pacific is expected to witness the highest growth during the forecast period, owing to government support in countries, such as China, Japan, and India; rise in pharmaceutical R&D expenditures, government support, and rising awareness towards generic drugs, along with the increasing number of CROs to provide preclinical and clinical research services.

Want to know which region offers the best growth opportunities? Register Here

Key Players

Some of the major key players in the viral clearance market are-

• BSL BIOSERVICE Scientific Laboratories Munich GmbH,
• Charles River Laboratories, Inc.,
• Clean Cells,
• Kedrion S.p.A.,
• Merck Group,
• Texcell,
• Vironova AB,
• ViruSure GmbH.

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, validation, and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Customization Option

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players).
• SWOT analysis of key players (up to three players).

Competitive Benchmarking

• Benchmarking of key players on the following parameters: product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@Stratviewresearch.com.